RT Journal Article
SR Electronic
A1 Shuman, Jill
T1 Safety and Efficacy of Dupilumab in Adults with Chronic AD
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 37
SP 13
OP 13
DO 10.1177/155989771437009
UL http://mdc.sagepub.com/content/14/37/13.1.abstract
AB Atopic dermatitis (AD) is a common, chronic skin condition induced by a type 2 helper T cell-mediated response to various environmental antigens. These cells release cytokines that promote occurrence and recurrence of AD. This article reviews safety and efficacy results from the phase 2b Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis [NCT01859988].